<!DOCTYPE html>

<html>
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<link href="../../../webpages.css" rel="stylesheet"/>
</head>
<body>
<div class="banner">
<div class="banner-content">
<h1>DermpathNet</h1>
</div>
</div>
<nav>
<a href="../../../index.html" target="_blank">
<text type="button">Home</text>
</a>
<a href="../../../browser-page-317.html" target="_blank">
<text type="button">Browse</text>
</a>
<a href="../../../download-page.html" target="_blank">
<text type="button">Downloads</text>
</a>
<a href="../../../contact-us.html" target="_blank">
<text type="button">About</text>
</a>
</nav>
<footer class="site-footer">
<p>@2024 New York University Grossman School of Medicine, Weill Cornell Medicine</p>
<!--<p>Privacy Policy | Terms of Service | Cookie Policy</p>-->
</footer>
<title>Sellar surprises: a single-centre experience of unusual sellar masses.-DermPath</title>
<div class="content-container"> <div class="figures-container"> <div class="image-side"> <img alt="Sellar surprises: a single-centre experience of unusual sellar masses." class="clickable-image" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf21/6993267/49644f5014f4/EC-19-0497fig6.jpg"/> </div> <div class="text-side"> <h1>Sellar surprises: a single-centre experience of unusual sellar masses.</h1> <p>Photomicrographs showing pathological features of case 9 (Malignant peripheral nerve sheath tumor) and case 10 (Metastasis from papillary thyroid carcinoma). Case 9 (malignant peripheral nerve sheath tumor): A1, tumor with moderate-high cellularity with spindle cells having focally palisading buckled nuclei (black arrowheads) and perivascular condensation of tumor cells (black arrow) (H&amp;E 400x); A2, tumor showing high proliferative index (MIB-1 index-12%); Case 10 (metastasis from papillary thyroid carcinoma): B1, tumour showing conspicuous follicular/microfolicular architecture (H&amp;E 200x) with typical nuclear clearing (as shown in the inset, H&amp;E 400x); B2, tumour is immunopositive for TTF1 (immunohistochemistry; 400x), thus confirming the primary papillary thyroid carcinoma.</p> <p>PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/31910151/" target="_blank">31910151</a></p><p>Type: Premalignant/Malignant, Category: Neural or neuroendocrine</p>
</div> </div></div></body></html>